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The catalytic asymmetric cyclopropanation of alkenes with diazo compounds constitutes aconvenient and direct strategy for the construction of optically active cyclopropanes, [1] which are key structural motifs in numerous natural products and pharmaceuticals. [2] Within this structural class,c yano-substituted cyclopropanes represent particularly attractive building blocks owing to the versatility of the cyano group toward its interconversion to avariety of functional groups.
[3] Moreover, cyano-functionalized cyclopropanes have been incorporated into pharmacologically active molecules,including the potent cathepsin Ki nhibitor Odanacatib. [4] Notable contributions from the Davies,C harette,a nd Zhang groups have recently introduced chemocatalytic protocols for the asymmetric synthesis of cyano-substituted cyclopropanes starting from donor-acceptor or acceptor-acceptor diazo compounds. [5] In stark contrast, methods for the asymmetric synthesis of cyano-substituted cyclopropanes using the acceptor-only diazo reagent diazoacetonitrile (N 2 CHCN) have remained elusive.A sa ni solated effort in this direction, chiral Ruporphyrins were reported to catalyze the cyclopropanation of styrene derivatives in the presence of pre-formed diazoacetonitrile (1a), but only with moderate diastereoselectivity (20-50 % de)a nd enantioselectivity (41-71 % ee) (Scheme 1). [6] More recently,the Koenigs group has reported the iron-catalyzed cyclopropanation of vinylarenes in the presence of in situ generated [7] diazoacetonitrile. [8] While offering good yields and scalability,t his method provides only moderate diastereoselectivity (2:1 to 7:1d .r.)a nd no enantioselectivity in the cyclopropanation reaction (Scheme 1). [8] Motivated by the shortcomings of current methodologies for this transformation, we have pursued and report herein the development of ab iocatalytic strategy for the highly stereoselective synthesis of nitrile-substituted cyclopropanes by myoglobin-catalyzed olefin functionalization with diazoacetonitrile.T his method provides ar ather general, efficient, and scalable route to enantiopure cyclopropanes incorporating ac yano group,w hich can be readily elaborated to afford variously functionalized chiral cyclopropanes.
Heme-containing proteins [9] as well as engineered/artificial metalloenzymes [10] have been recently identified as viable biocatalysts for promoting olefin cyclopropanations in the presence of diazo reagents.I np articular, we previously reported the ability of engineered variants of myoglobin (Mb) to catalyze the cyclopropanation of vinylstyrenes with ethyl a-diazoacetate (EDA) with ah igh degree of diastereoand enantioselectivity. [9c,d] Despite this progress,the scope of biocatalytic cyclopropanations has been largely restricted to a-diazoacetates,l imiting the types of functionalized cyclopropanes accessible using these systems.T oo vercome these limitations,o ur attention was drawn to diazoacetonitrile, al argely underutilized reagent in organic chemistry. [11] The application of pre-formed diazoacetonitrile in carbene transfer manifolds presents important challenges since this reagent cannot be handled easily due to its high volatility,toxicity,and explosive nature. [12] On the other hand, protocols for in situ Scheme 1. Methodsf or synthesis of nitrile-substituted cyclopropanes using diazoacetonitrile.
generation of diazoacetonitrile through diazotization of 2-amino-acetonitrile, [11, 13] as helf-stable,r eadily available,a nd inexpensive reagent, are incompatible with protein stability and function. Our recent success in engaging gaseous 2-diazotrifluoroethane (DTE) in myoglobin catalysis [9g] prompted us to apply an analogous compartmentalized reaction system for testing the ability of myoglobin to accept diazoacetonitrile as acarbene donor for olefin cyclopropanation. Accordingly,we tested ar eaction system in which diazoacetonitrile (1a), generated in situ by diazotization of 2-amino-acetonitrile (1b)i na"reagent generation chamber", is carried through a"reaction chamber" containing the biocatalyst and amodel olefin substrate (p-chloro-styrene, 2a)byacontinuous flow of inert gas (Ar) ( Table 1a nd Figure S1 in the Supporting Information). Them yoglobin variant Mb(H64V,V68A) was selected as the catalyst because of its high stereoselectivity in olefin cyclopropanations with EDA.
[9c,d] Gratifyingly,areaction system involving Mb(H64V,V68A)-containing whole cells (OD 600 :8 0) and ex situ generated diazoacetonitrile resulted in the accumulation of the desired nitrile-substituted cyclopropane product 3a in good conversion (44 %; Table 1 , Entry 2). Asimilar reaction with purified protein did not yield any product (Table 1 , Entry 1), indicating that the whole cell system protects the biocatalyst from inactivation by the gas flow.I mportantly,t he Mb(H64V,V68A)-catalyzed reaction was found to proceed also with excellent diastereo-and enantioselectivity (99.9 % de and ee), producing as ingle stereoisomer with trans-(1S,2S)a bsolute configuration as established by X-ray crystallography (Table 1; Figure S3 in the Supporting Information). These results thus showed that diazoacetonitrile can be effectively utilized as carbene donor by the Mb-based carbene transferase.Additionally,the chiral induction imposed by Mb(H64V,V68A) in the cyclopropanation reaction with diazoacetonitrile mirrors,which is observed in styrene cyclopropanation with EDA [9c] and DTE, [9g] highlighting the conserved stereoselectivity of this biocatalyst across these acceptor-only carbene donors.F urther experiments showed that other hemoproteins can catalyze this reaction, but only with lower activity and/or stereoselectivity compared to Mb(H64V,V68A) (Table S1 in the Supporting Information).
Based on the promise of these initial results,t he Mb(H64V,V68A)-catalyzed reaction was further optimized. Ad ecrease in catalyst loading (that is,c ell density (OD 600 ) from 80 to 5) showed ap rogressive increase in the catalytic turnovers (TON) supported by the hemoprotein (230!3110), while providing similar or higher product conversions (44-55 %) and maintaining excellent stereoselectivity (Table 1 , Entries 3-6). Because of its superior efficiency,acell density (OD 600 )o f2 0w as thus chosen for the subsequent studies. Upon observing that alarger excess of carbene precursor (10 vs.5equiv of 1b), generated over alonger time period (4 vs. 0.5 hours), did not lead to noticeable improvement in product conversion (Entry 7), we surmised that only part of the diazo compound produced in the reagent generation chamber is made available to the biocatalyst. We attributed this phenomenon to the high solubility of diazoacetonitrile in water, which would hamper its effective transfer to the reaction chamber.U pon optimization of the reagent generation reaction using different solvent systems (Table S2 in the Supporting information), we found that awater:toluene (1:1) mixture was optimal for maximizing both formation of the diazo reagent and its mass transfer to the reaction chamber, leading to improved product conversions of 72 %a nd 87 % over 5and 15 hours,respectively,with no impact on diastereoand enantioselectivity (Table 1, entry 8) . Moreover,t he reaction could be readily scaled up (from 10 to 30 mm pchlorostyrene, 2a), enabling the isolation of 86 mg of enantiopure 3a (99.9 % de and ee)i n8 1% yield (Table 1, entry 9) . Under these conditions,M b(H64V,V68A) catalyzes 5600 turnovers,which corresponds to an approximately 50 to 100-fold higher catalytic activity than reported with chemocatalytic systems (ca. 50-100 TON). [6, 8] To explore the scope of this reaction, ad iverse panel of styrene derivatives and vinylarenes was subjected to Mb(H64V,V68A)-catalyzed cyclopropanation with a-diazoacetonitrile under the optimized conditions described above and at ap reparative scale (0.6 mmol olefin) ( Table 2) . These experiments showed that styrene (2b)a sw ell as various styrene derivatives carrying para, meta,and ortho substituents (2c-2i)a re efficiently processed by the Mb(H64V,V68A) variant, leading to the corresponding cyclopropanation products 3b-3i in good to excellent conversion (50-99 %) and isolated yields (44-84 %) ( Table 2 ; Entries 1-2;4-8). Both electron-donating (3f-i)a nd electron-withdrawing substituents (3c, 3e)o nt he benzene ring of the olefin were equally (81 %) [f ] 5,600 99.9 99.9
[a] Reaction conditions: 10 mm 4-chloro-styrene( 2a), purified Mb variant (20 mm)orMb(H64V,V68A)-expressing E. coli (BL21(DE3)) cells in KPi 50 mm (pH 7), at 20 mL-scale, RT,5hours. NaNO 2 was slowly added over 30 min. [22] [b] Relative to olefin. well tolerated, although lower yields were obtained for 3d due to its volatility.Importantly,excellent levels of diastereoand enantioselectivity (96-> 99 % de and ee)w ere maintained for these styrenyl substrates.A dditionally,d ifferent vinylarenes such as naphthyl-, pyridyl-, and thiophenylsubstituted olefins could be efficiently transformed by the Mb(H64V,V68A) biocatalyst to give the corresponding cyclopropane products 3j, 3l,and 3m in good yields (61-71 %) and with high stereoselectivity (84-99 % de and ee)( Table 2 ; Entries 9, [11] [12] . Along with 3l and 3m,t he efficient synthesis of 3k in high enantiopurity further demonstrated the utility of Mb(H64V,V68A) for the cyclopropanation of a,a-disubstituted olefins (Entry 10), as well as olefins incorporating N-and S-containing heterocycles,w hich find widespread use in medicinal chemistry.
Theh igh catalytic activity of Mb(H64V,V68A) across these substrates (2080-4960 TON; Table 2 ) prompted us to investigate challenging substrates such as b-methyl-styrene, which has previously eluded Mb-catalyzed cyclopropanation with EDA.
[9c] Albeit in low yields, 3n and 3o could be obtained in enantioenriched form (4699 % ee), demonstrating the feasibility of the present methodology to access trisubstituted cyclopropanes (Table 2 ; Entries 13 and 14). Notably,t he catalytic activity of the iron-based Mb(H64V,V68A) in this reaction (110-380 TON) compares well with that reported for the cyclopropanation of b-methyl-styrene with EDA, using an artificial enzyme containing ah ighly reactive [14] iridium-porphyrin .
[10d] Altogether,t he results summarized in Table 2d enote the broad substrate scope of Mb(H64V,V68A)-mediated olefin cyclopropanation with diazoacetonitrile.Remarkably,this biocatalyst maintains high trans-(1S,2S)s tereoselectivity across the diverse arylarenes,a sjudged based on crystallographic analysis of 3c, 3d, and 3i ( Figure S4 -S6 in the Supporting Information), and the similar chromatographic behavior of the other products in chiral SFC or GC compared to that of the structurally characterized enantiopure products (Table S5-S8 in the  Supporting Information) .
Motivated by the positive results with a,b-disubstituted alkenes,w ef urther probed the capability of the method to enable the transformation of alkenes other than aryl-substituted olefins,w hose successful cyclopropanation with diazoacetonitrile was not previously reported. [6, 8] This group included unactivated substrates such as alkyl-substituted (5a,b)a nd electron-deficient olefins (5e,f). To our delight, all the reactions afforded the desired nitrile-substituted cyclopropane products 5a-f with modest to excellent diastereo-and enantioselectivity (Scheme 2).Notably,t he biocatalyst displayed over 4700 TONi nt he conversion of the acrylamide substrate 4f to 5f.T hese results further highlighted the generality of Mb(H64V,V68A)-catalyzed cyclopropanation reaction with diazoacetonitrile as well as its expanded scope compared to Mb-catalyzed cyclopropanation with a-diazoesters. [9c,d] While biocatalytic cyclopropanation reactions have so far remained largely confined to a-diazo esters, [9a-f,h,i,10, 15] we envisioned that akey advantage of the present strategy would lie in the possibility to access diverse cyclopropane structures by leveraging the versatile reactivity of the cyano group. [3] Illustrating this point, the enzymatically produced compound 3a could be further processed to access avariety of functionally diversified cyclopropanes (Scheme 3). Specifically,a lkaline hydrolysis of 3a readily produced the carboxy-and the carboxyamide-functionalized cyclopropanes 6 and 7,r espectively,i n5 1-84 %y ield in as ingle step.O nt he other hand, reduction of 3awith DIBAL furnished the formyl-substituted cyclopropane 8 in 83 %yield, whereas its reduction with LAH followed by N-benzoylation afforded the methylamino derivative 9 in 63 %y ield over two steps.O fn ote,m ethylaminocyclopropanes constitute the core structure of marketed drugs such as Tasimelteon [16] and Levomilnacipran. [17] Finally, az inc-catalyzed [2+ +3] cycloaddition reaction of 3a with NaN 3 [18] gave the tetrazole-substituted cyclopropane 10, whereas ar eaction with aminoethanol and zinc chloride [19] afforded the oxazoline-functionalized cyclopropane 11 in good yields (39-84 %). In most cases,t he transformation of the nitrile group occurred with no erosion of enantiopurity (> 99 % ee,Scheme 3).
In summary,w eh ave developed an efficient biocatalytic method for the highly diastereo-and enantioselective synthesis of nitrile-substituted cyclopropanes through the activation of diazoacetonitrile.T he present strategy offers unprecedented degrees of stereocontrol compared to previously reported chemocatalytic strategies (Scheme 1), along with high TON, scalability,a nd ab road substrate scope that extends beyond that of Mb-catalyzed cyclopropanations with a-diazoesters. [9c,d] Thel atter feature may stem from ah igher reactivity of the heme-carbene intermediate [20] generated from acetonitrile,a na spect that will be addressed in future studies.Describing the first example of abiocatalytic reaction involving diazoacetonitrile,t his study paves the way to the application of this reagent in the context of other metalloprotein-catalyzed carbene transfer reactions.This capability combined with the versatility of the cyano functional group,as exemplified by the transformations of Scheme 2, is expected to expand opportunities toward the exploitation of biocatalysis for asymmetric synthesis of pharmaceuticals and other high-value compounds. [21] 
